However, Riener EK reported that HER2 overexpression is not an independent prognostic factor for ovarian cancer, and its role for predicting disease needs to rest on other factors, such as, clinical stage, histological grade and residual tumor volume [16]. This evidence concerns the gene ERBB2 and neoplasm.